Pfizer (NYSE:PFE) shares are finally starting to attract attention after gaining close to 7% in a single trading session on news that it's reached a pricing deal with the Trump administration. Indeed, this is the biggest up day for shares of PFE in recent memory. And while investors are upbeat on the pricing plan, I do think that income investors should focus on the longer-term opportunity at hand.